GDP-d-mannose pyrophosphorylase catalyzes the production of GDP-dmannose, an intermediate product in the plant ascorbic acid (AsA) biosynthetic pathway. This enzyme is a key regulatory target in AsA biosynthesis and is encoded by VITAMIN C DEFECTIVE 1 (VTC1) in the Arabidopsis thaliana genome. Here, recombinant VTC1 was expressed, purified and crystallized. Diffraction data were obtained from VTC1 crystals grown in the absence and presence of substrate using X-rays. The ligand-free VTC1 crystal diffracted X-rays to 3.3 Å resolution and belonged to space group R32, with unit-cell parameters a = b = 183.6, c = 368.5 Å , = = 90, = 120
Introduction
Ascorbic acid (AsA), or vitamin C, commonly functions as an antioxidant and enzymatic cofactor in animals and plants (Englard & Seifter, 1986; Smirnoff, 2000; Foyer & Noctor, 2011) . Plants are the major AsA source for humans, in which the gene encoding the last enzyme in the AsA-biosynthetic pathway is mutated and its product is nonfunctional (Chatterjee, 1973) . AsA also plays a key role in plant growth and development by enhancing plant tolerance to various stresses (Hemavathi et al., 2010; Tó th et al., 2011; Vacca et al., 2004) .
The major AsA-biosynthetic pathway in plants starts from GDP-d-mannose (Smirnoff et al., 2001 ). This differs from AsA biosynthesis in most animals and the alternative pathway in plants and Euglena, which starts from UDP-d-glucose (Linster & van Schaftingen, 2007; Wheeler et al., 2015) . VITAMIN C DEFECTIVE 1 (VTC1)/CYTOKINESIS DEFECTIVE 1 (CYT1), hereafter referred to as VTC1, is a GDP-d-mannose pyrophosphorylase (GMPP) in the model plant Arabidopsis thaliana (Conklin et al., 1997; Nickle & Meinke, 1998; Lukowitz et al., 2001) . VTC1 catalyzes the conversion of d-mannose 1-phosphate to GDP-d-mannose, the first rate-limiting step of the major AsA-biosynthetic pathway in plants (Wheeler et al., 1998) . In the vtc1 mutant, the AsA level decreases 70% compared with the wild type (Conklin et al., 1997 (Conklin et al., , 1999 . VTC1 is tightly regulated by multiple mechanisms. At the transcriptional level, ETHYLENE RESPONSE FACTOR 98 acts as a positive regulator of VTC1 (Zhang et al., 2012) . At the post-translational level, the photomorphogenic factor # 2016 International Union of Crystallography COP9 signalosome subunit 5B interacts with VTC1 and promotes VTC1 degradation though proteasomes in the dark (Wang, Yu et al., 2013; . Recently, two VTC1 stimulators, KONJAC1 and KONJAC2, have been identified (Sawake et al., 2015) . Both proteins can interact with VTC1 and enhance its GMPP activity.
Despite the accumulated physiological studies of VTC1, the structural basis of the catalytic activity of this enzyme and its regulation is still unknown. Here, we report the purification, crystallization and diffraction of ligand-free VTC1 and VTC1 in the presence of its substrate.
Materials and methods

Protein expression and purification
The full-length gene for VTC1 (AT2G39770) was amplified from an A. thaliana cDNA library by PCR and was ligated into the pEASY-Blunt simple cloning vector (TransGen Biotech, People's Republic of China). The gene was inserted into the expression vector pET-28a(+) (Novagen) between NcoI and HindIII sites. The resulting plasmid encodes C-terminally His 6 -tagged VTC1. This plasmid was transformed into Escherichia coli strain BL21(DE3) and the cells were cultured in LB medium. When the cell density reached an OD 600 of 0.6-0.8, protein expression was introduced with 0.2 mM isopropyl -d-1-thiogalactopyranoside and the cells were grown at 289 K for 16 h. The cells were then harvested by centrifugation (5000g, 10 min) and resuspended in buffer A (20 mM Tris-HCl pH 7.5, 150 mM NaCl) supplemented with 20 mM imidazole. The cells were disrupted by ultrasonication on ice and were centrifuged at 30 000g for 30 min. The supernatant was loaded onto a pre-equilibrated Ni 2+ -nitrilotriacetic acid column (Qiagen) and the unbound protein was washed with buffer A supplemented with 20 mM imidazole. The recombinant protein was subsequently eluted with buffer A supplemented with 200 mM imidazole. The protein was further purified by gel-filtration chromatography using a HiLoad 16/60 Superdex 200 column (GE Healthcare) pre-equilibrated with buffer A. The elution peak was collected, pooled and concentrated by ultrafiltration with a 30 kDa cutoff centrifugal filter (Millipore). The purity and concentration were determined by SDS-PAGE and a Bradford assay, respectively. The expression information is given in Table 1 .
Crystallization
The sitting-drop vapour-diffusion technique was used for crystallization screening. The initial crystallization conditions for VTC1 without ligands were screened at 277 and 289 K using concentrations of 7.5 and 15 mg ml
À1
, respectively. The process was carried out by mixing protein and reservoir solution in a 1:1 volume ratio. The ligand-free VTC1 crystal was grown using 0.1 M bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane (bis-tris) pH 6.5, 25%(w/v) PEG 3350, 0.2 M lithium sulfate. The co-crystallization of VTC1 with GTP and d-mannose 1-phosphate was set up as for ligand-free VTC1. The VTC1 protein was incubated with GTP and d-mannose 1-phosphate in a 1:5:5 molar ratio on ice for 1 h. The cocrystallized VTC1 crystal was grown in 0.1 M magnesium formate, 15%(w/v) PEG 3350.
Data collection
All of the crystals were transferred to crystallization buffer supplemented with 10% glycerol for 30 s and flash-cooled in liquid nitrogen. All diffraction data were collected on beamline BL17U at Shanghai Synchrotron Radiation Facility at a wavelength of 0.9793 Å at 100 K and were recorded on an ADSC Quantum 315r detector with 0.5 s exposure for every 1 oscillation (Wang et al., 2015) . All data sets were processed, integrated and scaled with DENZO and SCALEPACK in the HKL-2000 package (Otwinowski & Minor, 1997) .
Results and discussion
To investigate the mechanism of catalysis by VTC1, we produced and crystallized full-length ligand-free VTC1 (Fig. 1a) . We also obtained crystals of VTC1 in the presence of GTP and d-mannose 1-phosphate (Fig. 1b) Table 2 Crystallization of ligand-free VTC1 and co-crystallized VTC1. Volume and ratio of drop 2 ml, 1:1 2 ml, 1:1 Volume of reservoir (ml) 200 200 Figure 3 The X-ray diffraction patterns of a ligand-free VTC1 crystal and a VTC1 crystal grown in the presence of substrate. molecules in solution may contain product molecules. The crystallization information is listed in Table 2 . We also confirmed the integrity of the VTC1 protein in the co-crystallized crystals. Crystals were picked up from the drop, washed with reservoir solution, dissolved in SDS-PAGE loading buffer and subsequently checked by SDS-PAGE. It showed only a single band near to 45 kDa (Fig. 2) , which corresponds to the molecular weight of VTC1. This band was then identified by the peptide mass fingerprinting method, with a top score of 198 and a sequence coverage of 61%.
Two data sets were collected and the statistics of data collection are summarized in Table 3 . The ligand-free VTC1 crystal diffracted X-rays to 3.3 Å resolution (Fig. 3a) and its space group is R32, which differs from that of the crystal of co-crystallized VTC1, with unit-cell parameters a = b = 183.6, c = 368.5 Å , = = 90, = 120
. The VTC1 crystals grown in the presence of substrate diffracted to a high resolution of 1.75 Å (Fig. 3b) , with space group P2 1 and unit-cell parameters a = 70.8, b = 83.9, c = 74.5 Å , = = 90.0, = 114.9
. We are working towards phase solution by single-wavelength anomalous dispersion using selenomethionine-containing crystals. 
